Introduction: The History of Arsenic Trioxide in Cancer Therapy

Karen H. Antman
The Oncologist 2001; 6(Supplement 2 ): 1-2; doi:10.1634/theoncologist.6-suppl_2-1
[Abstract] [Full Text] [PDF]  

History of the Development of Arsenic Derivatives in Cancer Therapy

Samuel Waxman, Kenneth C. Anderson
The Oncologist 2001; 6(Supplement 2 ): 3-10; doi:10.1634/theoncologist.6-suppl_2-3
[Abstract] [Full Text] [PDF]  

Clinical Experience of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia

Steven L. Soignet
The Oncologist 2001; 6(Supplement 2 ): 11-16; doi:10.1634/theoncologist.6-suppl_2-11
[Abstract] [Full Text] [PDF]  

Arsenic Trioxide: An Emerging Therapy for Multiple Myeloma

Nikhil C. Munshi
The Oncologist 2001; 6(Supplement 2 ): 17-21; doi:10.1634/theoncologist.6-suppl_2-17
[Abstract] [Full Text] [PDF]  

Clinical Trials of Arsenic Trioxide in Hematologic and Solid Tumors: Overview of the National Cancer Institute Cooperative Research and Development Studies

Anthony J. Murgo
The Oncologist 2001; 6(Supplement 2 ): 22-28; doi:10.1634/theoncologist.6-suppl_2-22
[Abstract] [Full Text] [PDF]  

Risk/Benefit Profile of Arsenic Trioxide

Deborah M. Rust, Steven L. Soignet
The Oncologist 2001; 6(Supplement 2 ): 29-32; doi:10.1634/theoncologist.6-suppl_2-29
[Abstract] [Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.